Nalaganje...

Modulating Th2 Cell Immunity for the Treatment of Asthma

It is estimated that more than 339 million people worldwide suffer from asthma. The leading cause of asthma development is the breakdown of immune tolerance to inhaled allergens, prompting the immune system's aberrant activation. During the early phase, also known as the sensitization phase, al...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Immunol
Main Authors: León, Beatriz, Ballesteros-Tato, Andre
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7902894/
https://ncbi.nlm.nih.gov/pubmed/33643321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.637948
Oznake: Označite
Brez oznak, prvi označite!